An expert opinion would be great, my simple mind says the DMC continuation could mean:
Worst case same as control group maybe slight improvement
Best case results that mirror phase 2
I don’t believe there are many options for these patients, which is why the DMC would not stop it even if the results are negligible and why it is such a potential gold mine.
The better argument is the MACE events ended at the expected date, which might mean the results mirror the expectation or the control group outperformed expectations
I think heart might fail but the CBLP will be a winner.
Remember when everyone said the LVAD was a sure success?
here's a thought, page-6
-
- There are more pages in this discussion • 11 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add MSB (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$1.13 |
Change
-0.025(2.17%) |
Mkt cap ! $1.284B | |||
| Open | High | Low | Value | Volume |
| $1.15 | $1.16 | $1.11 | $7.363M | 6.488M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 5 | 94863 | $1.13 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $1.13 | 5000 | 2 |
View Market Depth
| Last trade - 16.10pm 26/07/2024 (20 minute delay) ? |
| MSB (ASX) Chart |